Publications by authors named "L Fidani"

Methotrexate (MTX) is an anti-folate chemotherapeutic agent that is considered to be a gold standard in Acute Lymphoblastic Leukemia (ALL) therapy. Nevertheless, toxicities induced mainly due to high doses of MTX are still a challenge for clinical practice. MTX pharmacogenetics implicate various genes as predictors of MTX toxicity, especially those that participate in MTX intake like ().

View Article and Find Full Text PDF

Background: Single-nucleotide polymorphisms in , critical regulators of female growth and puberty, have been linked to age at menarche.

Methods: We assessed the association of , , and with menarcheal age in girls of Greek descent. We reviewed the records of 248 girls who had their first menstruation before 18 years and who attended the Greek Departments of Pediatric Endocrinology from January 2021 to July 2023.

View Article and Find Full Text PDF

Parkinson's disease (PD) is the second-most common neurodegenerative disease, affecting 1% of people aged over 60. Currently, there is only symptomatic relief for PD patients, with levodopa being the gold standard of PD treatment. Deep brain stimulation (DBS) is a surgical option to treat PD patients.

View Article and Find Full Text PDF
Article Synopsis
  • * Recent research is focused on identifying specific biomarkers and genetic factors to improve diagnosis and treatment options for KD, moving towards personalized medicine.
  • * The article emphasizes the importance of global collaboration in research and public awareness to enhance the understanding, management, and patient outcomes of KD.
View Article and Find Full Text PDF

The purpose of this study was to report on the menarcheal age in girls of Greek origin and assess its potential associations with their demographic and perinatal data, as well as their maternal menarcheal age. In this case-control study, adolescent girls were recruited between September 2021 and September 2022 from two Pediatric Endocrinology Units, Aristotle University of Thessaloniki, Greece. Eligible participants included Greek girls up to the age of 18 years, with menarche and the absence of chronic disease or chronic medication use.

View Article and Find Full Text PDF